Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Bevacizumab rechallenge after first line maintenance bevacizumab.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bevacizumab rechallenge after first line maintenance bevacizumab.
Konstantinopoulos PA, Berlin ST, Campos SM, Matulonis UA, Cannistra SA. Bevacizumab rechallenge after first line maintenance bevacizumab. Gynecol Oncol. 2012 May; 125(2):510-1.
View in:
PubMed
subject areas
Adult
Aged
Angiogenesis Inhibitors
Drug Administration Schedule
Endometrial Neoplasms
Fallopian Tube Neoplasms
Female
Humans
Middle Aged
Peritoneal Neoplasms
Recurrence
authors with profiles
Panagiotis Konstantinopoulos, Ph.D., M.D.
Stephen A. Cannistra, M.D.
Susana Maria Campos, M.D.
Ursula Anne Matulonis, M.D.